Legal & General Group
ACRS icon

Legal & General Group’s Aclaris Therapeutics ACRS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$11.7K Buy
+8,242
New +$11.7K ﹤0.01% 3227
2024
Q2
Sell
-9,646
Closed -$12K 3414
2024
Q1
$12K Sell
9,646
-40,249
-81% -$50.1K ﹤0.01% 3161
2023
Q4
$52.4K Hold
49,895
﹤0.01% 2800
2023
Q3
$342K Buy
49,895
+6,156
+14% +$42.2K ﹤0.01% 2585
2023
Q2
$454K Buy
43,739
+22,691
+108% +$235K ﹤0.01% 2496
2023
Q1
$170K Buy
21,048
+939
+5% +$7.6K ﹤0.01% 2641
2022
Q4
$317K Buy
20,109
+485
+2% +$7.64K ﹤0.01% 2449
2022
Q3
$308K Buy
19,624
+1,935
+11% +$30.4K ﹤0.01% 2468
2022
Q2
$247K Buy
17,689
+1,088
+7% +$15.2K ﹤0.01% 2559
2022
Q1
$286K Buy
16,601
+876
+6% +$15.1K ﹤0.01% 2550
2021
Q4
$229K Buy
15,725
+107
+0.7% +$1.56K ﹤0.01% 2673
2021
Q3
$281K Buy
15,618
+9,446
+153% +$170K ﹤0.01% 2581
2021
Q2
$109K Buy
+6,172
New +$109K ﹤0.01% 2701
2020
Q2
Sell
-5,519
Closed -$6K 3407
2020
Q1
$6K Hold
5,519
﹤0.01% 3234
2019
Q4
$10K Hold
5,519
﹤0.01% 3292
2019
Q3
$6K Hold
5,519
﹤0.01% 3314
2019
Q2
$12K Sell
5,519
-976
-15% -$2.12K ﹤0.01% 3324
2019
Q1
$39K Hold
6,495
﹤0.01% 2801
2018
Q4
$48K Buy
6,495
+2,536
+64% +$18.7K ﹤0.01% 2703
2018
Q3
$57K Hold
3,959
﹤0.01% 2703
2018
Q2
$79K Sell
3,959
-27
-0.7% -$539 ﹤0.01% 2562
2018
Q1
$70K Sell
3,986
-1,505
-27% -$26.4K ﹤0.01% 2605
2017
Q4
$136K Sell
5,491
-181
-3% -$4.48K ﹤0.01% 2456
2017
Q3
$146K Buy
5,672
+418
+8% +$10.8K ﹤0.01% 2449
2017
Q2
$142K Buy
5,254
+2,605
+98% +$70.4K ﹤0.01% 2435
2017
Q1
$79K Sell
2,649
-104
-4% -$3.1K ﹤0.01% 2672
2016
Q4
$75K Buy
2,753
+1,115
+68% +$30.4K ﹤0.01% 2716
2016
Q3
$42K Hold
1,638
﹤0.01% 2601
2016
Q2
$31K Buy
+1,638
New +$31K ﹤0.01% 2712